Invivyd (IVVD) Cash from Financing Activities (2021 - 2025)
Invivyd (IVVD) reported Cash from Financing Activities of $157.18 million for Q4 2025, compared with $77,000 a year earlier and up 169.5% from the prior quarter.
Invivyd (IVVD) Cash from Financing Activities (2021 - 2025) Analysis & Trends
For FY2025, Invivyd posted Cash from Financing Activities of $215.63 million, up 448.2% from FY2024.
- Cash from Financing Activities has a five-year compound annual growth rate of 10.7% (FY2020 to FY2025).
- By year, Cash from Financing Activities came in at $39.33 million in FY2024, $1.05 million in FY2023 (+106.5%), $506,000 in FY2022 (-99.9%) and $662.68 million in FY2021 (+411.5%).
- The Q4 2025 figure ranks as the highest quarterly Cash from Financing Activities since Q3 2021.
- Year over year, Cash from Financing Activities gained in 1 of the last five quarters, with an average decline of 40.5%.
- The high point for year-over-year Cash from Financing Activities in five years was Q2 2023 (growth of 264.9%); the low point was Q2 2022 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $58.31 million (Q3 2025), $131,000 (Q2 2025) and $10,000 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Invivyd | 256.44 Mn | -250.20 Mn | 13.01 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 157.18 Mn |
| Sep 30, 2025 | 58.31 Mn |
| Jun 30, 2025 | 131,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 77,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Mar 31, 2024 | 39.10 Mn |
| Dec 31, 2023 | 141,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Jun 30, 2023 | 270,000.00 |
| Mar 31, 2023 | 542,000.00 |
| Dec 31, 2022 | 141,000.00 |
| Sep 30, 2022 | 246,000.00 |
| Jun 30, 2022 | 74,000.00 |
| Mar 31, 2022 | 45,000.00 |
| Dec 31, 2021 | -749,000.00 |
| Sep 30, 2021 | 328.60 Mn |
| Jun 30, 2021 | 334.83 Mn |
Invivyd Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IVVD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "IVVD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IVVD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();